In addition, we found that Uygur patients with breast cancer with 2‐3 combined risk genotypes of ERCC1 had a higher risk than that of individuals with 0‐1 risk genotypes (OR = 2.91; 95% CI = 1.54‐5.71, p = 0.001). This evidence concerns the gene ERCC1 and breast cancer.